Article
Recent therapeutic advances in chronic lymphocytic leukemia
2017-10-31
Abstract excerpt
The last several years have witnessed a paradigm shift in the management of patients with chronic lymphocytic leukemia (CLL). The course of this very heterogeneous disease, traditionally treated with chemotherapeutic agents usually in combination with rituximab, typically has been characterized by remissions and relapses, and survival times vary greatly, depending on intrinsic biological attributes of the leukemia...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0baae966-b535-56d7-b017-56717b27f0af
- DOI
- 10.12688/f1000research.11618.1